Company / Working Capital
STANDARD BIOTOOLS INC. Working Capital History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$346.0M
FY2025
5-year range
$22.5M / $346.0M
FY2021-FY2025
Trend
+11.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Working Capital has fluctuated over the past 10 years, ranging from $22M in FY2021 to $346M in FY2025.
Based on SEC 10-K filings.
$346M in FY2025 with a 5-year CAGR of +40.4%.
Improved from $49M to $346M over the past 2 years.
Working Capital over time
Growth rates
- 3-Year CAGR
- +27.9%
- 5-Year CAGR
- +40.4%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +40.4%, indicating consistent growth.
- In FY2025, working capital increased 11.6% year-over-year.
- Lowest working capital in the period was in FY2021.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $346.0M | +11.6% |
| FY2024 | $310.0M | +534.1% |
| FY2023 | $48.9M | -70.4% |
| FY2022 | $165.4M | +635.1% |
| FY2021 | $22.5M | -64.5% |
| FY2020 | $63.4M | +0.2% |
| FY2019 | $63.3M | +10.3% |
| FY2018 | $57.4M | -6.4% |
| FY2017 | $61.3M | -8.7% |
| FY2016 | $67.2M | -41.1% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026